Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 48 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  2. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  3. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  4. US 8003112

    Meningococcal and pneumococcal conjugate vaccine and method of using same

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  5. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  6. US 8003406

    Methods for detecting attention-deficit/hyperactivity disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  7. US 7999071

    Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  8. US 7989501

    Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  9. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  10. US 7939639

    Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2011 · Expires May 5, 2031

    granted

  11. US 7928079

    Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  12. US 7928096

    Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  13. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  14. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  15. US 7842798

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  16. US 7785565

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  17. US 7641909

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  18. US 7619057

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted

  19. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  20. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  21. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  22. US 7498336

    Deazaflavin compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted

  23. US 7459536

    HGF-SF monoclonal antibody combinations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  24. US 7456222

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.